BEROTRALSTAT

Clinical Indication

Prevention of recurrent attacks of hereditary angioedema (HEA)

Date of classification

September 2021

Review date

September 2021

Red

Drugs which should be prescribed only by hospital specialists (clinical review by specialist as appropriate and annually as a minimum).